www.precisionmedicineonline.com Open in urlscan Pro
2606:4700::6812:1037 Public Scan

Back to summary

Submitted URL:
https://www.precisionmedicineonline.com/#/login
Effective URL:
https://www.precisionmedicineonline.com/
Submission: On October 01 via manual (October 1st 2024, 1:40:42 am UTC) — Scanned from DE

Form analysis
3 forms found in the DOM

GET /elastic-search

<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
  <div class="js-form-item form-item form-element__textfield">
    <input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
      data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
  </div>
  <div class="js-form-item form-item form-element__submit">
    <button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
      <svg class="icon">
        <use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
      </svg>
    </button>
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>

GET /elastic-search

<form action="/elastic-search" method="get" id="views-exposed-form-search-autocomplete-page" accept-charset="UTF-8">
  <div class="js-form-item form-item form-element__textfield">
    <input class="elastic-autocomplete-input form-autocomplete form-text form-item__textfield ui-autocomplete-input" placeholder="Enter your keywords" data-drupal-selector="edit-search-phrase"
      data-autocomplete-path="/admin/view_content/search_autocomplete" type="text" id="edit-search-phrase" name="search_phrase" value="" size="30" maxlength="128" data-once="autocomplete" autocomplete="off">
  </div>
  <div class="js-form-item form-item form-element__submit">
    <button class="button button--icon js-form-submit form-submit" aria-label="button" title="Search">
      <svg class="icon">
        <use xlink:href="/profiles/custom/crain_core/themes/custom/gweb/dist/icons.svg#magnifying-glass"></use>
      </svg>
    </button>
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions"></div>
</form>

Name: form-login —

<form name="form-login">
  <div>
    <div class="u-mt-6">
      <div class=""><label data-testid="label" for="email" class="u-mb-2 u-block u-text-base u-text-neutral-700 md:u-text-lg">Email Address*</label><input type="email"
          class="focus:u-border-primary focus:u-ring-primary u-block u-w-full u-rounded u-border u-border-neutral-950 u-px-4 u-py-3.5 u-text-lg u-font-normal u-leading-7 u-text-neutral-950 focus:u-outline-none focus:u-ring-1 placeholder:u-text-base placeholder:u-font-normal placeholder:u-text-neutral-500 md:placeholder:u-text-lg u-bg-white"
          name="email" placeholder="Enter email address" id="email"></div>
    </div>
  </div>
  <div>
    <div class="u-mt-6">
      <div class=""><label data-testid="label" for="password" class="u-mb-2 u-block u-text-base u-text-neutral-700 md:u-text-lg">Password*</label><input type="password"
          class="focus:u-border-primary focus:u-ring-primary u-block u-w-full u-rounded u-border u-border-neutral-950 u-px-4 u-py-3.5 u-text-lg u-font-normal u-leading-7 u-text-neutral-950 focus:u-outline-none focus:u-ring-1 placeholder:u-text-base placeholder:u-font-normal placeholder:u-text-neutral-500 md:placeholder:u-text-lg u-bg-white"
          name="password" placeholder="Enter password" id="password"></div>
    </div>
  </div>
  <div>
    <div class="u-mt-4 u-flex u-justify-start md:u-justify-end"><button type="button"
        class="u-inline-flex u-items-center u-justify-center u-min-w-fit u-transition u-ease-in-out u-duration-200 u-text-sm u-text-primary u-underline u-font-semibold"><span class="u-sr-only">Forgot your password?</span>Forgot your
        password?</button></div>
  </div>
  <div class="u-mt-6 u-flex u-justify-end"><button type="submit"
      class="u-inline-flex u-items-center u-justify-center u-border-2 u-border-primary u-rounded hover:u-border-primary-300 active:u-border-primary-400 u-text-lg md:u-text-base u-min-w-[180px] u-px-8 u-py-4 u-transition u-ease-in-out u-duration-200 hover:u-bg-primary-300 u-bg-primary u-text-white u-font-bold u-whitespace-nowrap u-grow md:u-grow-0"><span
        class="u-sr-only">Login</span>Login</button></div>
</form>

Text Content

Skip to main content


SISTER PUBLICATION LINKS

 * GenomeWeb
 * 360Dx
 * Precision Medicine Online
 * PMLS Events


Premium Trial:

Request an Annual Quote


USER ACCOUNT MENU

 * My Account
   * Profile
   * Newsletters
   * My Topics
   * Reading List
   * Log out

Log in
Subscribe
Menu
Close Menu


MAIN NAVIGATION

 * My Account
   * Profile
   * Newsletters
   * My Topics
   * Reading List
   * Log out
 * Business & Policy
   * Business News
   * Regulatory News
   * Reimbursement
 * Precision Oncology
   * Breast Cancer
   * Lung Cancer
   * Colorectal Cancer
   * Prostate Cancer
   * Ovarian Cancer
   * Brain Cancer
   * Melanoma
   * Pediatric Cancer
   * Minimal Residual Disease
   * Microsatellite Instability Testing
   * Immunotherapy
 * Diagnostics
   * Companion Diagnostics
   * Clinical Sequencing
   * Liquid Biopsy
 * Disease Areas
   * Rare Disease
   * Inherited Disease
   * Cardiovascular disease
   * Neurological and Psychological Disorders
   * Autoimmune Disease
 * Precision Medicine Trends
   * Pharmacogenomics
   * Polygenic Risk Scores
   * Gene Editing
   * Cell Therapy
   * Gene Therapy
 * Resources
   * Webinars
   * White Papers
   * Partner Content
   * Virtual Molecular Tumor Board Series
   * Genetic Testing Challenges in Oncology Series




Premium Trial:

Request an Annual Quote

Log in
Subscribe



ALL OF US PROGRAM LOOKING TO PUBLIC-PRIVATE PARTNERSHIPS, OTHER FUNDING AMID
BUDGET UNCERTAINTY
PREMIUM

In a report, a working group cautioned that the program must lessen its reliance
on congressional appropriations or risk "squandering" investments made so far.


GENETIC COUNSELORS CAN HELP PATIENTS SORT CONCERNS, SET EXPECTATIONS FOR GENE
THERAPIES
PREMIUM

During a panel discussion at the National Society of Genetic Counselors meeting,
genetic counselors discussed the risks and benefits of gene therapies.


FDA PANEL FINDS LIMITED IMMUNOTHERAPY BENEFIT IN PD-L1-NEGATIVE GASTRIC,
ESOPHAGEAL CANCER
PREMIUM

The agency is considering whether to limit the indications of Keytruda, Opdivo,
and Tevimbra to PD-L1-positive patients amid testing uncertainties. 


AI TOOL SHOWS PROMISE FOR PREDICTING GENOMIC ALTERATIONS IN LUNG CANCER
PREMIUM

Researchers hope DeepGEM can expedite targeted treatment for lung cancer
patients who can't access standard genomic testing.


CASE STUDY SUGGESTS ROLE FOR TARGETED THERAPY IN FGFR2 FUSION-POSITIVE
PANCREATIC CANCER
PREMIUM

Researchers are planning a clinical trial after four metastatic FGFR2
fusion-positive pancreatic cancer patients responded to FGFR-directed therapy. 
Business, Policy & Funding


 * PRIME MEDICINE PIPELINE PRIORITIZATION, LICENSING DEAL WITH BMS TO FUND
   OPERATIONS INTO 2026


 * C2N DIAGNOSTICS RECEIVES $15M FROM GHR FOUNDATION FOR DEVELOPMENT OF TAU
   TESTS FOR ALZHEIMER'S


 * DIGITAL PATHOLOGY FIRM MINDPEAK RAISES $15.3M IN SERIES A FINANCING ROUND


 * FDA GRANTS FULL APPROVAL TO ELI LILLY'S RETEVMO IN RET-MUTANT MEDULLARY
   THYROID CANCER


 * FDA PANEL FINDS LIMITED IMMUNOTHERAPY BENEFIT IN PD-L1-NEGATIVE GASTRIC,
   ESOPHAGEAL CANCER
   PREMIUM

Precision Oncology


 * NOVIGENIX DEVELOPING LIQUID BIOPSY TEST TO GUIDE TREATMENT OF AGGRESSIVE
   PROSTATE CANCER
   PREMIUM


 * PRIME MEDICINE PIPELINE PRIORITIZATION, LICENSING DEAL WITH BMS TO FUND
   OPERATIONS INTO 2026


 * BIOAI, ARBELE TEAM UP TO DEVELOP AI-BASED BIOMARKER SCREENING TEST


 * DIGITAL PATHOLOGY FIRM MINDPEAK RAISES $15.3M IN SERIES A FINANCING ROUND


 * CASE STUDY SUGGESTS ROLE FOR TARGETED THERAPY IN FGFR2 FUSION-POSITIVE
   PANCREATIC CANCER
   PREMIUM

Precision Medicine Diagnostics


 * NOVIGENIX DEVELOPING LIQUID BIOPSY TEST TO GUIDE TREATMENT OF AGGRESSIVE
   PROSTATE CANCER
   PREMIUM


 * TESSELLATE BIO PARTNERS WITH AUSTRALIAN RESEARCH INSTITUTES TO STUDY
   ALT-DRIVEN CANCERS


 * PRIME MEDICINE PIPELINE PRIORITIZATION, LICENSING DEAL WITH BMS TO FUND
   OPERATIONS INTO 2026


 * BIOAI, ARBELE TEAM UP TO DEVELOP AI-BASED BIOMARKER SCREENING TEST


 * C2N DIAGNOSTICS RECEIVES $15M FROM GHR FOUNDATION FOR DEVELOPMENT OF TAU
   TESTS FOR ALZHEIMER'S

Disease Areas


 * NOVIGENIX DEVELOPING LIQUID BIOPSY TEST TO GUIDE TREATMENT OF AGGRESSIVE
   PROSTATE CANCER
   PREMIUM


 * PRIME MEDICINE PIPELINE PRIORITIZATION, LICENSING DEAL WITH BMS TO FUND
   OPERATIONS INTO 2026


 * BIOAI, ARBELE TEAM UP TO DEVELOP AI-BASED BIOMARKER SCREENING TEST


 * C2N DIAGNOSTICS RECEIVES $15M FROM GHR FOUNDATION FOR DEVELOPMENT OF TAU
   TESTS FOR ALZHEIMER'S


 * DIGITAL PATHOLOGY FIRM MINDPEAK RAISES $15.3M IN SERIES A FINANCING ROUND

Breaking News


 * TESSELLATE BIO PARTNERS WITH AUSTRALIAN RESEARCH INSTITUTES TO STUDY
   ALT-DRIVEN CANCERS


 * PRIME MEDICINE PIPELINE PRIORITIZATION, LICENSING DEAL WITH BMS TO FUND
   OPERATIONS INTO 2026


 * BIOAI, ARBELE TEAM UP TO DEVELOP AI-BASED BIOMARKER SCREENING TEST


 * C2N DIAGNOSTICS RECEIVES $15M FROM GHR FOUNDATION FOR DEVELOPMENT OF TAU
   TESTS FOR ALZHEIMER'S


 * DIGITAL PATHOLOGY FIRM MINDPEAK RAISES $15.3M IN SERIES A FINANCING ROUND


 * FDA GRANTS FULL APPROVAL TO ELI LILLY'S RETEVMO IN RET-MUTANT MEDULLARY
   THYROID CANCER



What's Popular?


 1. POST-IPO, TEMPUS FOCUSES ON REGULATORY APPROVALS AND GROWING BUSINESS
    PREMIUM


 2. FDA GRANTS FULL APPROVAL TO ELI LILLY'S RETEVMO IN RET-MUTANT MEDULLARY
    THYROID CANCER


 3. FDA PANEL FINDS LIMITED IMMUNOTHERAPY BENEFIT IN PD-L1-NEGATIVE GASTRIC,
    ESOPHAGEAL CANCER
    PREMIUM


 4. CASE STUDY SUGGESTS ROLE FOR TARGETED THERAPY IN FGFR2 FUSION-POSITIVE
    PANCREATIC CANCER
    PREMIUM


 5. IN BRIEF THIS WEEK: UNIQURE, WHO, VERTEX, LONZA, ELIXIRGEN, ELI LILLY,
    CLEARNOTE HEALTH, PENN STATE





SPONSORSHIPS





FOOTER

 * About us
 * Advertise
 * Contact
 * FAQ
 * Jobs
 * Sitemap
 * Submit A Tip



Privacy Policy.  Terms & Conditions. Copyright © 2024 GenomeWeb, a business unit
of Crain Communications.  All Rights Reserved.

Our site uses cookies and related technologies, as described in our 
Datenschutzerklärung, for purposes that may include site operation, analytics,
enhanced user experience, or advertising. You may choose to consent to our use
of these technologies or manage your own preferences.
Akzeptieren Ablehnen Einstellungen verwalten



LOG IN TO YOUR ACCOUNT

CloseClose
Email Address*
Password*
Forgot your password?Forgot your password?
LoginLogin
Don’t have an account yet?
Create an account
Create an account.

Registered Precision Medicine Online Users - Please Log In
Due to a system upgrade, please click on the Log In button on the upper right
side of the page to access Precision Medicine Online content.

www.precisionmedicineonline.com Open in urlscan Pro 2606:4700::6812:1037 Public Scan

Form analysis 3 forms found in the DOM

GET /elastic-search

GET /elastic-search

Name: form-login —

Text Content

www.precisionmedicineonline.com Open in urlscan Pro
2606:4700::6812:1037 Public Scan

Form analysis
3 forms found in the DOM